European Archives - Page 402 of 899 - European Medical Journal

Continue

The fight against the superbugs

How can the pharmaceutical industry and, in particular, medical affairs teams, take pragmatic approaches to combat and curb antimicrobial resistance?

Picking the perfect campaign star

Celebrity endorsements can transform a mediocre pharma campaign into a pitch-perfect hit, but choosing the right spokesperson is crucial. We explore the practice of attaching famous faces to campaigns and how to ensure a representative strikes the right chord

Talking to Patrick Romano

Patrick Romano, Co-founder and Partner, Eradigm Consulting, talks about his experience as a biochemist, how to build pharmaceutical value propositions fit for the future, and how the industry can navigate the blurring of lines between pharma and public health.
EMJ Respiratory 8.1 2020 Feature Image
November 2020

EMJ Respiratory 8.1 2020

EMJ Respiratory features an impressive collection of new and fascinating research, alongside our independent review of the virtual European Respiratory Society (ERS) International Congress 2020 with research and breaking news from the virtual event.
2 Mins
27th October 2020

A Randomised Controlled Trial of Acute Health Effects in Patients with Chronic Obstructive Pulmonary Disease After Passive Vape Exposure from e-cigarettes

Since their introduction to the European and USA markets in 2006–2007, electronic cigarettes (e-cigarettes) have become popular nicotine-delivery devices…
EMJ Respiratory 8.1 2020 Feature Image
12 Mins
27th October 2020

Review of the virtual European Respiratory Society (ERS) International Congress 2020

THE 30th anniversary of the European Respiratory Society (ERS) meeting was set to be a spectacle in Vienna, Austria, but no one could predict…
2 Mins
27th October 2020

Altered Iron Metabolism and Elevated Cellular Senescence in Chronic Obstructive Pulmonary Disease Small Airway Epithelial Cells

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that affects nearly 10% of people over the age of 40 years…
10 Mins
27th October 2020

The Treatment of Severe Respiratory Disorders in Challenging Times

Prof Welte described COVID-19, caused by the new coronavirus strain severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), as a disease…
7 Mins
27th October 2020

Successful Inhalation Therapy in 2020: Patients and Inhalers in Focus

Prof Rabe first showed the current Global Initiative for Chronic Obstructive Lung Disease (GOLD) initial treatment guidelines and explained the reasoning…
EMJ Respiratory 8.1 2020 Feature Image
1 Mins
27th October 2020

The Impact of a Stewardship Programme on Outcomes in Patients Admitted with Community-Acquired Pneumonia

Community-acquired pneumonia (CAP) is a common cause of antibiotic prescription, hospital admission, and mortality…